Related Experiment Videos
Ciprofloxacin as treatment for conjunctivitis.
1Center of Ocular Microbiology-University of Catania, Catania, Italy. GChisari@Unict.it
Journal of Chemotherapy (Florence, Italy)
|June 26, 2004
Summary
Ciprofloxacin effectively treats bacterial conjunctivitis and blepharoconjunctivitis, achieving a 95% success rate. This antibiotic demonstrated significant bactericidal action and therapeutic effectiveness in ocular infections.
Area of Science:
- Ophthalmology
- Microbiology
- Pharmacology
Background:
- External ocular infections, including bacterial conjunctivitis and blepharoconjunctivitis, are common conditions.
- Identifying causative bacteria and their antibiotic susceptibility is crucial for effective treatment.
Purpose of the Study:
- To evaluate the bactericidal action and therapeutic effectiveness of ciprofloxacin.
- To assess ciprofloxacin's efficacy in treating bacterial conjunctivitis and blepharoconjunctivitis.
Main Methods:
- A study involving 108 ambulatory patients with external ocular infections.
- Conjunctival swabs were collected before and after therapy for bacterial identification and susceptibility testing.
- Routine microbiological methods were employed for analysis.
Main Results:
- Ciprofloxacin demonstrated a 95% therapeutic success rate in treating bacterial conjunctivitis and blepharoconjunctivitis.
- Bacteriological analysis confirmed the effectiveness of ciprofloxacin against identified pathogens.
- In vitro tests corroborated the in vivo therapeutic outcomes.
Conclusions:
- Ciprofloxacin is a highly effective antibiotic for treating external ocular bacterial infections.
- Its efficacy extends to infections with challenging etiological identification.
- The study confirms ciprofloxacin's role in managing bacterial conjunctivitis and blepharoconjunctivitis.